4574 TAIKO PHARMACEUTICAL CO.,LTD.大幸薬品TSE Prime / Pharmaceuticals
0 posts
TAIKO PHARMACEUTICAL CO.,LTD. (4574) at a glance
Prices are from Yahoo! Finance and may be delayed. Always check the latest price before trading.
TAIKO PHARMACEUTICAL CO.,LTD. (4574) Stock Price HistoryNear a 52-week low
TAIKO PHARMACEUTICAL CO.,LTD. closed at ¥244 on Nov 20, 2026, −7.6% over 1 month, −16.2% over 1 year.
If you had invested ¥100,000 1 month ago, it would be worth ¥92,424 today (−7.6%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved −11.9%, while this stock moved −7.6%.
Last 10 Trading Days
| Date | Close | Change | % Change |
|---|---|---|---|
| Nov 20 (Fri) | ¥244 | −10 | −3.94% |
| Nov 19 (Thu) | ¥254 | −4 | −1.55% |
| Nov 17 (Tue) | ¥258 | +0 | +0.00% |
| Nov 16 (Mon) | ¥258 | −5 | −1.90% |
| Nov 13 (Fri) | ¥263 | −2 | −0.75% |
| Nov 12 (Thu) | ¥265 | +6 | +2.32% |
| Nov 11 (Wed) | ¥259 | −2 | −0.77% |
| Nov 10 (Tue) | ¥261 | +1 | +0.38% |
| Nov 9 (Mon) | ¥260 | +0 | +0.00% |
| Nov 6 (Fri) | ¥260 | −6 | −2.26% |
If you had invested ¥100,000 3 months ago, it would be worth ¥91,045 today (−9.0%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved −14.8%, while this stock moved −9.0%.
Last 10 Trading Days
| Date | Close | Change | % Change |
|---|---|---|---|
| Nov 20 (Fri) | ¥244 | −10 | −3.94% |
| Nov 19 (Thu) | ¥254 | −4 | −1.55% |
| Nov 17 (Tue) | ¥258 | +0 | +0.00% |
| Nov 16 (Mon) | ¥258 | −5 | −1.90% |
| Nov 13 (Fri) | ¥263 | −2 | −0.75% |
| Nov 12 (Thu) | ¥265 | +6 | +2.32% |
| Nov 11 (Wed) | ¥259 | −2 | −0.77% |
| Nov 10 (Tue) | ¥261 | +1 | +0.38% |
| Nov 9 (Mon) | ¥260 | +0 | +0.00% |
| Nov 6 (Fri) | ¥260 | −6 | −2.26% |
If you had invested ¥100,000 6 months ago, it would be worth ¥95,686 today (−4.3%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved −5.6%, while this stock moved −4.3%.
Monthly Closes
| Month | Month-End Close | Monthly % |
|---|---|---|
| Nov 2026 | ¥244 | −6.2% |
| Oct 2026 | ¥260 | +2.4% |
| Sep 2026 | ¥254 | −3.4% |
| Aug 2026 | ¥263 | +4.0% |
| Jul 2026 | ¥253 | −10.6% |
| Jun 2026 | ¥283 | +10.5% |
| May 2026 | ¥256 | −12.3% |
If you had invested ¥100,000 1 year ago, it would be worth ¥83,849 today (−16.2%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +13.3%, while this stock moved −16.2%.
Monthly Closes
| Month | Month-End Close | Monthly % |
|---|---|---|
| Nov 2026 | ¥244 | −6.2% |
| Oct 2026 | ¥260 | +2.4% |
| Sep 2026 | ¥254 | −3.4% |
| Aug 2026 | ¥263 | +4.0% |
| Jul 2026 | ¥253 | −10.6% |
| Jun 2026 | ¥283 | +10.5% |
| May 2026 | ¥256 | −12.3% |
| Apr 2026 | ¥292 | −1.0% |
| Mar 2026 | ¥295 | −6.6% |
| Feb 2026 | ¥316 | +10.9% |
| Jan 2026 | ¥285 | −4.4% |
| Dec 2025 | ¥298 | −1.3% |
| Nov 2025 | ¥302 | ― |
If you had invested ¥100,000 3 years ago, it would be worth ¥76,730 today (−23.3%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +67.8%, while this stock moved −23.3%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | ¥244 | −18.1% |
| 2025 | ¥298 | ― |
If you had invested ¥100,000 5 years ago, it would be worth ¥31,525 today (−68.5%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +96.3%, while this stock moved −68.5%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | ¥244 | −18.1% |
| 2025 | ¥298 | ― |
If you had invested ¥100,000 in Apr 2009, it would be worth ¥55,455 today (−44.5%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +466.7%, while this stock moved −44.5%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | ¥244 | −18.1% |
| 2025 | ¥298 | −10.0% |
| 2024 | ¥331 | +9.2% |
| 2023 | ¥303 | −23.1% |
| 2022 | ¥394 | −52.2% |
| 2021 | ¥824 | −48.9% |
| 2020 | ¥1,612 | +47.7% |
| 2019 | ¥1,092 | +68.1% |
| 2018 | ¥649 | −18.3% |
| 2017 | ¥795 | +28.7% |
| 2016 | ¥618 | +1.3% |
| 2015 | ¥610 | −9.1% |
| 2014 | ¥671 | −15.9% |
| 2013 | ¥798 | +181.9% |
| 2012 | ¥283 | +8.8% |
| 2011 | ¥260 | −33.6% |
| 2010 | ¥391 | −38.9% |
| 2009 | ¥641 | ― |
Daily, weekly and monthly closes (Yahoo! Finance, split-adjusted, dividends excluded). "All" covers the range Yahoo provides (from Apr 2009). Please check the latest prices before trading.
TAIKO PHARMACEUTICAL CO.,LTD. (4574) financial indicators
PER, ROE and dividend yield are based on company forecasts, calculated from earnings reports and the closing price after each trading day.
Key features of TAIKO PHARMACEUTICAL CO.,LTD. (4574)
Business overview
Together with five subsidiaries, the company runs pharmaceutical, infection control and other businesses. The pharmaceutical business makes over-the-counter drugs centered on 「正露丸」 and 「セイロガン糖衣A」 and sells them in Japan and abroad. 「正露丸」, with a history of more than 120 years, maintains high brand recognition in Japan, and the company also sells the capsule-type 「正露丸クイックC」, the antidiarrheal 「ピシャット下痢止めOD錠」 that can be taken without water, and the quasi-drug 「ラッパ整腸薬BF」. In Japan it sells through pharmacies and drugstores. Overseas, it sells in Hong Kong and China and in Taiwan through subsidiaries, and in the United States, Canada, Thailand, Malaysia and Mongolia through exports via agents. In China it sells to the South China market from its Hong Kong base and is expanding sales channels to East, North and Northeast China.
Summarized from the annual securities report (fiscal year ended December 2025) filed on EDINET.
Position within Pharmaceuticals (79 companies)
| Dividend yield | 1.43% | No. 34 in the sector (highest first); median 2.97% |
|---|---|---|
| PER | 22.3x | Above the sector median of 16.5x (No. 26 from the lowest) |
| PBR | 1.44x | Below the sector median of 1.86x (No. 26 from the lowest) |
| ROE | 6.45% | No. 22 in the sector (highest first); median 4.17% |
| Market cap | ¥12.3 bn | No. 43 in the sector (largest first) |
Ranks among stocks in the same Tokyo Stock Exchange sector (33 sectors). PER and PBR of zero or below (losses, negative equity) are excluded and ranked from the lowest.
Price milestones
| 52-week high | ¥316 | 2/27 |
|---|---|---|
| 52-week low | ¥244 | 11/20 |
| Current position | 0.0% | Where the low is 0% and the high is 100% (close on 11/20: ¥244) |
| Year to date | -18.1% | No. 43 of 77 in the sector (best first) |
| 1 year | -16.1% |
Based on closing prices (adjusted for stock splits, excluding dividends).
Calculated as of 2026/11/20 17:30 JST. Updated every business day in the evening.
Recent disclosures (TDnet, in Japanese)
- 11/13 15:302026年12月期(FY2026) 第3四半期決算短信〔日本基準〕(連結)
- 11/13 15:302026年12月期(FY2026)第3四半期連結決算報告
- 10/26 16:00スタンダード市場への市場区分変更承認及びプライム市場の上場維持基準への適合に向けた計画の取り下げに関するお知らせ
Filings from the past 12 months (3).
Posts
This board is shared with the Japanese and Chinese versions. Feel free to write in English, Chinese or Japanese.
No posts yet. Be the first to write something.
Write on the TAIKO PHARMACEUTICAL CO.,LTD. board
More Japanese stocks in English
- CanBas Co.,Ltd.4575
- D.Western Therapeutics Institute, Inc.4576
- Daito Pharmaceutical Co.,Ltd.4577
- RaQualia Pharma Inc.4579
- Le Lien Co.,Ltd.457A
- SymBio Pharmaceuticals Limited4582
- Chiome Bioscience Inc.4583
- Kidswell Bio Corporation4584
- Medrx Co.,Ltd.4586
- PeptiDream Inc.4587
- Oncolys BioPharma Inc.4588
- PLAN DO Co.,Ltd.458A